Franklin Covey (FC) announced that its Board of Directors has approved replenishing the Company’s authorization to repurchase up to an aggregate amount of $50 million of its outstanding common stock. The Board also authorized the adoption of a 10b5-1 trading plan that will facilitate consistent share repurchases in compliance with applicable securities law. As previously reported on the Company’s fiscal Q3 2025 earnings call, Franklin Covey had repurchased approximately $17 million of its common stock on the open market in FY2025 and had approximately $28 million remaining as of May 31, 2025, under the Board’s prior $50 million repurchase authorization. This new reauthorization includes any amounts remaining under the Company’s existing program. “Consistent with our strategic and capital allocation priorities, we believe that making up to $50 million available in our share repurchase program and adopting a 10b5-1 plan are effective tools to return capital to shareholders,” said Paul Walker, Chief Executive Officer. “We believe that our current share price does not reflect the value which we expect our business plan to deliver to shareholders in the coming years and believe that expanding our repurchase program at this time provides us with the opportunity to capture significant additional value for our shareholders.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FC:
- Franklin Covey Announces Leadership Change in Enterprise Division
- Franklin Covey management to meet virtually with Roth MKM
- Franklin Covey price target lowered to $27 from $30 at Roth Capital
- 3 Best Stocks to Buy Now, 7/7/2025, According to Top Analysts
- Franklin Covey’s Earnings Call: Mixed Outlook Amid Challenges